- Home
- Automated
- List of product information
- URIPAX FILM COATED TABLET 200MG [SIN16400P]
URIPAX FILM COATED TABLET 200MG [SIN16400P]
Active ingredients: URIPAX FILM COATED TABLET 200MG
Last updated 26 October 2025
Product Info
URIPAX FILM COATED TABLET 200MG
[SIN16400P]
Product information
Active Ingredient and Strength | FLAVOXATE HYDROCHLORIDE - 200 MG |
Dosage Form | TABLET, FILM COATED |
Manufacturer and Country | Y.S.P. INDUSTRIES (M) SDN. BHD. - MALAYSIA |
Registration Number | SIN16400P |
Licence Holder | YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | G04BD02 |
Indication(s):
Symptomatic relief of dysuria, urgency, vesical suprapubic pain, nocturia, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis and urethrotrigonitis. Relief of vesico-urethral spasm due to catheterization, cystoscopy or indwelling catheters, prior to cystoscopy or catheterisation, and sequelae of surgical intervention of the lower urinary tract.
Dosage and Administration:
Adults (including the elderly): The recommended adult dosage is 200mg three times a day for as long as required.
Children: Not recommended for children under 12 years of age.
Contraindication(s):
Flavoxate is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients, gastrointestinal obstructive conditions or ileus, gastrointestinal haemorrhage, achalasia, urinary retention, glaucoma and myasthenia gravis.